could be a dead cat bounce, who knows...I bought some ZGEN because they have a drug in phase 3 trial for lupus that works like HGSI's Benlysta, but it binds to BLyS and APRIL, and Benlysta only binds to Blys, so in theory, it should work better (maybe too good? we don't really know what cause Lupus, we do know that it is related to too much B cells, and BLyS and APRIL are implicated in B cell survival, maturation and antibody production, so by binding to BLys and APRIL, it will lower the amount of B cell, thus lower antibody in your body, so they won't start attacking your own cells) than Benlysta.
jessieqwert
Senior member
- Jun 21, 2003
- 955
- 1
- 81
Anyone here following GERN?
They look like they have some interesting things going on. There should be upcoming news on a novel treatment for crippling spinal injuries (newsweek just posted an article about it that ppl have people jumping up and down). There are also quite a few more preliminary treatments under development (i.e. not human testing yet), like something that has the potential to kill certain cancer cells, one for osteoporosis, and another one that can manufacture insulin in the body. This is all embryonic stem cell based research and it sounds like GERN is leading the way. They're collaborating with the likes of GE Healthcare, Merck, and others. So it's not just developing drugs/treatments but also intellectual property related to working with stem cells.
Looks like they have enough money to carry on w/trials for at least another year and no debts. They also hold the intellectual rights to techs related to animal cloning (i.e. dolly the sheep), which apparently can be used to do things like increase milk production or raise disease resistance. In 2008, the FDA ruled these animals are safe so GERN will probably be generating license income within the next few years.
They look like they have some interesting things going on. There should be upcoming news on a novel treatment for crippling spinal injuries (newsweek just posted an article about it that ppl have people jumping up and down). There are also quite a few more preliminary treatments under development (i.e. not human testing yet), like something that has the potential to kill certain cancer cells, one for osteoporosis, and another one that can manufacture insulin in the body. This is all embryonic stem cell based research and it sounds like GERN is leading the way. They're collaborating with the likes of GE Healthcare, Merck, and others. So it's not just developing drugs/treatments but also intellectual property related to working with stem cells.
Looks like they have enough money to carry on w/trials for at least another year and no debts. They also hold the intellectual rights to techs related to animal cloning (i.e. dolly the sheep), which apparently can be used to do things like increase milk production or raise disease resistance. In 2008, the FDA ruled these animals are safe so GERN will probably be generating license income within the next few years.
I am wondering how the market will do this week with about ~230 billion in debt being sold by the treasury. We might get a pull-back of some sort before we go higher.
- Jan 23, 2002
- 2,206
- 12
- 81
There's always the possibility of appeals, that's why you want a judge who is thorough and fair so the case is as bullet-proof as possible.
Quite frankly, if Rambus wins $3 to $12 billion dollars, I don't care if it gets appealed. The stock would go nuts.
BTW, there's two trials happening at the end of this year... the ITC case against Nvidia and the AT case against the memory cartel.
- Jan 23, 2002
- 2,206
- 12
- 81
Judge Folsom just heard sanctions in the case of TIVO vs ECHOSTAR (Dish Network).
TIVO is asking for $1 billion in damages and Echostar is stating that damages should be no more than $100 million, or $300 million max.
The hearing lasted an hour and Judge Folsom stated that he will have the decision "well in advance" of the CAFC procedures in November. The quotations were his words.
I already own Jan 2011 $20 calls, but I'm going to take a risky gamble on near-term price movements. I just bought Sept 2010 $15 calls. Got them for 14 cents.
TIVO is asking for $1 billion in damages and Echostar is stating that damages should be no more than $100 million, or $300 million max.
The hearing lasted an hour and Judge Folsom stated that he will have the decision "well in advance" of the CAFC procedures in November. The quotations were his words.
I already own Jan 2011 $20 calls, but I'm going to take a risky gamble on near-term price movements. I just bought Sept 2010 $15 calls. Got them for 14 cents.
- Jan 23, 2002
- 2,206
- 12
- 81
I'm assuming this was the Aug 2009 options? If so, I'm not sure where you got $6 million, GT. This is what I come up with:
2000 contracts x (.05 x 100) per contract = 2000 x $5 = $10,000
You can sell Aug 2009 $12.50's for $2.35 right now, so:
2000 contracts x ($2.35 x 100) per contract = 2000 x $235 = $470,000
So if Yoxxy has what he stated he did and at those prices, he would have made:
$470,000 proceeds - $10,000 cost = $460,000 profit minus any commission costs and before taxes
But on the flip side, lets say for example, the shares are now $2 & there was no way of movement, is he obligated to buy them at $12.50 when the expiry date comes or he can just let the contracts expire & just loose the 10k?
Edit: I almost forgot, Congratulations Yoxxy!
that doesn't make sense to me. Are you not in a contractual agreement that on the August strike date you'll buy that share for $12.50 each regardless of what the actual price of the share at the given August strike date?
Scenario 1: August strike date share price = $14 each
He buys the shares at $12.50, which is a $1.50 profit on each share.
Scenario 2: August strike date share price = $10 each
He buys the shares at $12.50 & looses $2.50 on each share and the guy who sold that contract makes the $2.50 profit right?
I own a bunch of September $10 and December $10 calls. Up about 100% on each, more on the September calls because they were cheaper to buy in the beginning and time value is diminishing on both at this point. I'll probably hold on for a little longer. Also have a small long position.
An option is just that - an option to buy an equity at a specific price OR to sell an equity at a specific price on or before the exercise date (european options only allow you to exercise at expiration). If options are in the money, they will usually be automatically exercised by your broker, but you can close them out manually the day before. I don't ever exercise options - usually just trade them out.
There is no "requirement" to buy or sell or exercise.
EDIT: and as far as Scenario 2, he could do that... if he wanted to. No one would stop him for early exercise of the options. But he'd be stupid to do that when he can buy the shares on the open market for $10.
TRENDING THREADS
-
Discussion Zen 5 Speculation (EPYC Turin and Strix Point/Granite Ridge - Ryzen 9000)- Started by DisEnchantment
- Replies: 25K
-
Discussion Intel Meteor, Arrow, Lunar & Panther Lakes + WCL Discussion Threads
- Started by Tigerick
- Replies: 24K
-
Discussion Intel current and future Lakes & Rapids thread- Started by TheF34RChannel
- Replies: 23K
-
-
Facebook
Twitter